Loading...
XLONCRL
Market cap28mUSD
Dec 24, Last price  
33.50GBP
1D
0.00%
1Q
1.52%
Jan 2017
106.15%
Name

Creightons PLC

Chart & Performance

D1W1MN
XLON:CRL chart
P/E
—
P/S
43.10
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
-0.30%
Rev. gr., 5y
3.85%
Revenues
53m
-9.17%
11,354,00012,568,00012,917,00015,369,00015,155,00013,590,00014,130,00016,333,00017,326,00019,352,00020,171,00021,005,00030,586,00034,810,00044,030,00047,808,00061,605,00061,157,00058,567,00053,194,000
Net income
-4m
L
-363,000823,000383,000503,000378,000303,000134,700223,000302,000471,000851,000561,0001,251,0001,232,0002,891,0003,168,0004,334,0003,110,000514,000-3,527,000
CFO
6m
+3.70%
117,000580,000-1,310,000830,0001,438,000151,000-160,300339,000306,000689,000677,000980,0002,057,999-413,000989,0006,539,0005,413,0001,222,0005,812,0006,027,000
Dividend
Aug 08, 20240.45 GBP/sh
Earnings
Jul 16, 2025

Profile

Creightons Plc, together with its subsidiaries, develops, manufactures, and markets toiletries and fragrances in the United Kingdom and internationally. It offers haircare, skincare, bath and body, wellbeing, and male grooming products. The company also offers private label products for high street retailers and supermarket chains; and engages in the contract manufacturing business on behalf of third-party brand owners. It offers its products under the Argan Smooth, Balance Active Formula, Bambeautiful, Beautiful Brunette, Body Bliss, Bronze Ambition, Creightons, Charcoal, Creightons Frizz No More, Creightons H2O Boost, Creightons Pink Grapefruit, Creightons Pro Keratin, Crème de Cocunut & Keratin, Feather & Down, Humble Beauty, PureTouch, Salicylic Acid, Sunshine Blonde, Superfruits, and The Curl Company brands. The company also provides its products online. Creightons Plc was founded in 1954 and is based in Peterborough, the United Kingdom.
URL
https://www.creightons.com/
IPO date
Oct 16, 1986
Employees
421
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
53,194
-9.17%
58,567
-4.24%
61,157
-0.73%
Cost of revenue
51,656
57,621
57,729
Unusual Expense (Income)
NOPBT
1,538
946
3,428
NOPBT Margin
2.89%
1.62%
5.61%
Operating Taxes
250
173
345
Tax Rate
16.25%
18.29%
10.06%
NOPAT
1,288
773
3,083
Net income
(3,527)
-786.19%
514
-83.47%
3,110
-28.24%
Dividends
(428)
Dividend yield
0.91%
Proceeds from repurchase of equity
2
(502)
328
BB yield
-0.01%
2.20%
-0.69%
Debt
Debt current
971
2,875
2,966
Long-term debt
3,932
4,405
5,250
Deferred revenue
4,405
5,250
Other long-term liabilities
(3,488)
(4,386)
Net debt
1,765
5,627
7,376
Cash flow
Cash from operating activities
6,027
5,812
1,222
CAPEX
(321)
(1,140)
(1,730)
Cash from investing activities
(608)
(2,639)
(8,091)
Cash from financing activities
(3,947)
(2,351)
1,158
FCF
5,308
2,742
(3,237)
Balance
Cash
3,138
1,653
840
Long term investments
Excess cash
478
Stockholders' equity
18,315
24,033
21,251
Invested Capital
25,496
32,756
32,994
ROIC
4.42%
2.35%
13.49%
ROCE
5.54%
2.65%
9.62%
EV
Common stock shares outstanding
68,434
78,701
78,054
Price
0.25
-13.79%
0.29
-52.07%
0.61
-23.42%
Market cap
17,108
-25.04%
22,823
-51.67%
47,223
-18.72%
EV
18,873
28,450
54,599
EBITDA
3,256
2,528
5,007
EV/EBITDA
5.80
11.25
10.90
Interest
353
420
308
Interest/NOPBT
22.95%
44.40%
8.98%